Notice of Nexstim Plc Half-Yearly Report H1 201610.08.2016 08:00:00 CET
Company announcement, Helsinki, 10 August 2016, at 9:00 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, will publish its half-yearly report for the six months ended 30 June 2016 on Wednesday 17 August 2016 at approximately 9.00 am Finnish time.
A conference call for media, investors and analysts will take place at 3.00 pm Finnish time on Wednesday 17 August 2016. Martin Jamieson, Chairman and CEO, and Mikko Karvinen, CFO, will present the financial and operational results followed by a Q&A session.
The dial-in numbers for the conference call are:
Finland: +358 9 23195187
Sweden: +46 850336434
UK: +44 1452 555 566
US: +1 631 5107 498
The call ID number is: 58978731
Financial statements release for the year ending 31 December, 2016 will be published on or about 28 February 2017.
NEXSTIM PLC
Martin Jamieson, Chairman & CEO
Further information is available on the website www.nexstim.com or by contacting:
Nexstim +447715163942
Martin Jamieson, Chairman & CEO martin.jamieson@nexstim.com
UB Securities Oy (Certified Adviser) +358 (0)9 2538 0246
Consilium Strategic Communications +44 (0)20 3709 5700
Mary-Jane Elliott / Ivar Milligan / Laura Thornton nexstim@consilium-comms.com
About Nexstim Plc
Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a system called Navigated Brain Therapy (NBTŪ) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com